These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38544389)

  • 1. Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study.
    Zhang Y; Cui J; Liu F; Song Y; Wang Q; Liu Y; Zhang Y; Li Z; Chang Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2330163. PubMed ID: 38544389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
    Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
    Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
    Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
    Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
    Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
    Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L
    Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 9. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.
    Shen YS; Chow YH; Fang CY; Wu SR; Chen CH; Huang MH; Liao CL; Chiang JR; Liu CC
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1121-1128. PubMed ID: 37919172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine.
    Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of EV-A71 Vaccine and Its Impact on the Incidence of Hand, Foot and Mouth Disease: A Systematic Review.
    Hu Q; Xie Y; Ji F; Zhao F; Song X; Lu S; Li Z; Geng J; Yang H; Long J; Jin Y; Chen S; Duan G
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
    Wang J; Jiang L; Zhang C; He W; Tan Y; Ning C
    Vaccine; 2021 Jun; 39(25):3319-3323. PubMed ID: 33994239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines.
    Zhang X; Zhang Y; Li H; Liu L
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial-temporal-demographic and virological changes of hand, foot and mouth disease incidence after vaccination in a vulnerable region of China.
    Huang L; Wang T; Liu X; Fu Y; Zhang S; Chu Q; Nie T; Tu H; Cheng J; Fan Y
    BMC Public Health; 2022 Aug; 22(1):1468. PubMed ID: 35915424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
    Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
    Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.